Henry Meds Tirzepatide Pricing in 2026 — and the Flat-Price Alternative

If you searched for Henry Meds tirzepatide pricing, you probably already know the basics: it’s a well-known telehealth brand, it’s been around since 2022, and it has built a large patient base in the compounded GLP-1 space. What’s harder to find is a clear, current breakdown of what compounded tirzepatide actually costs there on a monthly and annual basis — and what the alternative looks like if flat pricing without a subscription matters to you.

This isn’t a takedown. Henry Meds is a legitimate provider with a straightforward program structure, and plenty of patients are well served by it. Below is the real published pricing, an honest look at what Henry Meds does well, and a side-by-side comparison with SkinnyVIP’s flat-price model — so you can decide which billing structure fits how you actually want to pay for treatment.

Henry Meds Compounded Tirzepatide: Published 2026 Pricing

Per Henry Meds’ published programs page and a 2026 Innerbody Research review, Henry Meds’ compounded injectable tirzepatide runs approximately $399 for the first month and $449 per month thereafter, billed on a recurring monthly subscription. Their compounded semaglutide is priced separately at approximately $297 per month.

Those prices are the entry point for a standard dose. Historically, Henry Meds and similar subscription-based programs have added roughly $100 a month as a patient’s dose is titrated upward — which is a normal part of GLP-1 treatment, not an edge case. Since dose-tier pricing can change, it’s worth confirming the exact current breakdown directly at signup rather than relying on any published number, including the ones in this article.

What the Henry Meds monthly price is reported to include: the clinician visit, the compounded medication itself, injection supplies where applicable, and shipping. There is no separate platform or membership fee layered on top of the medication price — the $449 figure is reported to be the full recurring charge, not a partial one. That’s a genuinely clean structure compared to programs that split a low medication price from a separate membership fee.

The billing model is a standard monthly subscription: you’re charged automatically each month, and the relationship continues until you actively cancel. For patients who want predictable, ongoing monthly billing without thinking about it, that’s a feature, not a bug. For patients who want to pay once and decide later whether to continue, it’s worth knowing upfront.

What Henry Meds Does Well

Credit where it’s due. A few things Henry Meds gets right:

• Established brand with a large patient base. Henry Meds has operated since 2022 and has treated a substantial number of patients, which means the operational kinks of a telehealth compounding program — intake, pharmacy fulfillment, follow-up cadence — are well worn-in.
• Good general reputation. Independent reviews, including coverage from Forbes Health and Innerbody Research, generally describe Henry Meds as a solid, straightforward option in the compounded GLP-1 category.
• No separate membership fee layered on medication. Unlike some competitors that charge a base medication price plus a recurring platform fee, Henry Meds’ published price is reported to be the full monthly charge.
• Simple program structure. The programs page is public and lays out pricing by medication and format without requiring an account to view baseline numbers.
• Monthly billing cadence some patients prefer. A recurring subscription means you don’t have to think about re-ordering — it just continues until you tell it to stop.

If brand recognition, an established track record, and set-it-and-forget-it monthly billing matter most to you, Henry Meds is a reasonable choice worth considering.

The Annual Math

Monthly prices are easy to compare and easy to underestimate over a full year. Here's what twelve months actually looks like at each provider's published starting rate:

• Henry Meds: $449/month × 12 months = ~$5,388 per year (before accounting for any dose-tier increases, which would push the total higher)
• SkinnyVIP: $695 per 3-month plan × 4 plans per year = ~$2,780 per year (flat, regardless of dose within the 2.5–15 mg range)

That's a difference of roughly $2,600 over twelve months, using each provider's published starting pricing as of mid-2026. The gap would be larger if Henry Meds' dose-based pricing increases apply, since SkinnyVIP's flat rate doesn't change as the dose goes up within a plan. Individual costs will vary, and both providers' pricing is subject to change, so this comparison is a starting point for your own math — not a guarantee of what either provider will charge you specifically.

Dose Escalation: Where Subscription Pricing Gets Expensive

GLP-1 treatment almost always involves dose titration — starting low and increasing over weeks or months as tolerated. This is standard clinical practice, not an exception. The pricing implication matters more than most patients realize going in.

Many subscription-based compounded GLP-1 providers price by dose tier: a lower starting dose costs less per month, and the price increases as the dose increases. That structure is common across the industry, not unique to any single company — but it means the price you're quoted at signup, at a low starting dose, often isn't the price you'll be paying once you reach a therapeutic maintenance dose several months in. If you're comparing a monthly subscription quote to a flat-rate quote, make sure you're comparing the price at the dose you'll actually end up taking, not the entry-tier price.

SkinnyVIP's plans are built differently: the price is set once, for the plan, and it covers the full range from 2.5 to 15 mg per week. Whether your clinician starts you low and titrates you up to a maintenance dose within that range, the price for the plan doesn't change. That's the core mechanical difference between a dose-tiered subscription and a flat-rate plan — and it's the main reason the annual math above widens as treatment continues.

Which Is Right for You

Both providers are legitimate options. The right choice depends on what you're optimizing for.

• Choose Henry Meds if: you value an established, well-known brand with a large existing patient base, you prefer a straightforward monthly subscription you don't have to think about renewing, and you're comfortable with pricing that may rise as your dose increases.
• Choose SkinnyVIP if: flat, predictable pricing matters more than brand recognition, you'd rather not have a recurring subscription running in the background, you want the price to stay the same regardless of which dose your clinician prescribes within the supported range, and you want the option to walk away at the end of a plan without an auto-renewal charge.

For a wider look at how these two models and other providers stack up across the category, see our full 4-provider pricing comparison. If you're also weighing a domestic compounding pharmacy model against a telehealth-plus-pharmacy model, the SkinnyRx vs SkinnyVIP comparison covers that distinction in more depth.

Whichever direction you go, ask any provider the same three questions before you pay: What is the most I'll pay in any given month, including everything? Does that price change as my dose changes? And can I stop without a recurring charge continuing in the background? A provider that can answer all three plainly, in under a minute, is one worth trusting with your treatment.